Healthpeak Properties (NYSE:DOC) Price Target Raised to $26.00 at Royal Bank of Canada

Healthpeak Properties (NYSE:DOC) had its target price increased by investment analysts at Royal Bank of Canada from $25.00 to $26.00 in a research report issued on Monday, Benzinga reports. The firm presently has an “outperform” rating on the real estate investment trust’s stock. Royal Bank of Canada’s price target would indicate a potential upside of 15.50% from the company’s previous close.

DOC has been the subject of a number of other research reports. Evercore ISI lifted their price target on shares of Healthpeak Properties from $25.00 to $26.00 and gave the stock an “outperform” rating in a research note on Monday, September 16th. Wedbush increased their price target on shares of Healthpeak Properties from $22.00 to $25.00 and gave the stock an “outperform” rating in a research report on Monday, July 29th. StockNews.com lowered Healthpeak Properties from a “hold” rating to a “sell” rating in a report on Wednesday, October 30th. Scotiabank increased their target price on Healthpeak Properties from $23.00 to $24.00 and gave the stock a “sector outperform” rating in a report on Monday, September 9th. Finally, Robert W. Baird boosted their price target on Healthpeak Properties from $24.00 to $25.00 and gave the company an “outperform” rating in a report on Wednesday, October 30th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating, ten have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $22.86.

Healthpeak Properties Stock Performance

Healthpeak Properties stock opened at $22.51 on Monday. Healthpeak Properties has a 12-month low of $15.44 and a 12-month high of $23.26. The company has a debt-to-equity ratio of 0.93, a current ratio of 1.31 and a quick ratio of 1.31. The company has a market capitalization of $15.74 billion, a price-to-earnings ratio of 47.89, a price-to-earnings-growth ratio of 2.45 and a beta of 1.13. The firm’s fifty day moving average price is $22.30 and its 200 day moving average price is $20.89.

Healthpeak Properties (NYSE:DOC) last released its quarterly earnings results on Thursday, October 24th. The real estate investment trust reported $0.12 EPS for the quarter, missing the consensus estimate of $0.44 by ($0.32). Healthpeak Properties had a return on equity of 3.53% and a net margin of 12.10%. The business had revenue of $700.40 million during the quarter, compared to analyst estimates of $682.51 million. During the same quarter last year, the firm posted $0.45 EPS. The company’s revenue was up 25.9% compared to the same quarter last year. On average, research analysts forecast that Healthpeak Properties will post 1.8 EPS for the current fiscal year.

Hedge Funds Weigh In On Healthpeak Properties

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Sumitomo Mitsui Trust Group Inc. bought a new position in shares of Healthpeak Properties in the third quarter worth $102,615,000. abrdn plc acquired a new stake in Healthpeak Properties in the third quarter worth about $62,670,000. Douglas Lane & Associates LLC bought a new position in Healthpeak Properties in the 3rd quarter valued at about $33,947,000. Foresight Group Ltd Liability Partnership acquired a new position in Healthpeak Properties during the 3rd quarter valued at about $33,212,000. Finally, Victory Capital Management Inc. bought a new stake in shares of Healthpeak Properties during the 3rd quarter worth about $32,470,000. 93.57% of the stock is owned by institutional investors.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.